TXTM (ProText Mobility) FCF Margin %: -23,800.00% (As of Sep. 2014)


What is ProText Mobility FCF Margin %?

ProText Mobility TXTM FCF Margin % is -23,800.00% as of Sep. 2014.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ProText Mobility's Free Cash Flow for the three months ended in Sep. 2014 was $-0.24 Mil. ProText Mobility's Revenue for the three months ended in Sep. 2014 was $0.00 Mil. Therefore, ProText Mobility's FCF Margin % for the quarter that ended in Sep. 2014 was -23,800.00%.

As of today, ProText Mobility's current FCF Yield % is -1.61%.

The historical rank and industry rank for ProText Mobility's FCF Margin % or its related term are showing as below:

TXTM' s FCF Margin % Range Over the Past 10 Years
Min: -70600   Med: 0   Max: 0
Current: -70600

TXTM's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -85.21 vs TXTM: -70600.00

ProText Mobility FCF Margin % Related Terms

ProText Mobility FCF Margin % Historical Data

* Premium members only.

The historical data trend for ProText Mobility's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProText Mobility FCF Margin % Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,925.81 -8,300.00 -3,665.38 -5,727.27 -36,600.00

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -23,800.00

TXTM vs DRSV, YPPN, CYBF: FCF Margin % Comparison

For the Biotechnology subindustry, ProText Mobility's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProText Mobility FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ProText Mobility's FCF Margin % falls into.


ProText Mobility FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ProText Mobility's FCF Margin for the fiscal year that ended in Dec. 2013 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=-0.366/0.001
=-36,600.00 %

ProText Mobility's FCF Margin for the quarter that ended in Sep. 2014 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2014 )/Revenue (Q: Sep. 2014 )
=-0.238/0.001
=-23,800.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -23,800.00% mean?
ProText Mobility (TXTM) has a FCF Margin % of -23,800.00% as of Sep. 2014. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ProText Mobility and its competitors.
Is ProText Mobility's FCF Margin % too high?
ProText Mobility's current FCF Margin % is -23,800.00%.
How does ProText Mobility's FCF Margin % compare to DRSV and YPPN?
ProText Mobility's FCF Margin % of -23,800.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ProText Mobility and its competitors. ProText Mobility's current FCF Margin % is -23,800.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProText Mobility stock overvalued right now?
ProText Mobility (TXTM) has a current FCF Margin % of -23,800.00%. The current FCF Margin % is -23,800.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ProText Mobility (TXTM), the current FCF Margin % is -23,800.00% as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProText Mobility Business Description

Address One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD-Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes and technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products, all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.